140 related articles for article (PubMed ID: 15716694)
1. Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population.
Beilby JP; Chapman CM; Palmer LJ; McQuillan BM; Thompson PL; Hung J
J Hypertens; 2005 Mar; 23(3):537-42. PubMed ID: 15716694
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
Gnasso A; Motti C; Irace C; Carallo C; Liberatoscioli L; Bernardini S; Massoud R; Mattioli PL; Federici G; Cortese C
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1600-5. PubMed ID: 10845878
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Liu PY; Chen JH; Li YH; Wu HL; Shi GY
Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
Terashima M; Akita H; Kanazawa K; Inoue N; Yamada S; Ito K; Matsuda Y; Takai E; Iwai C; Kurogane H; Yoshida Y; Yokoyama M
Circulation; 1999 Jun; 99(21):2717-9. PubMed ID: 10351963
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinase-3 genotype distribution and its relation with blood pressure profiles in Guangzhou rural population].
Shao Y; Deng M; Lian Z; Shi M; Jiang X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):586-9. PubMed ID: 23644126
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Sherva R; Ford CE; Eckfeldt JH; Davis BR; Boerwinkle E; Arnett DK
Stroke; 2011 Feb; 42(2):330-5. PubMed ID: 21183746
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin gene promoter polymorphism and common carotid geometry in diabetic subjects.
Irace C; Cortese C; Migale M; Liberatoscioli L; Mannucci L; Federici G; Gnasso A
Int Angiol; 2008 Oct; 27(5):413-8. PubMed ID: 18974705
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
Djurić T; Zivković M; Radak D; Jekić D; Radak S; Stojković L; Raicević R; Stanković A; Alavantić D
Clin Biochem; 2008 Nov; 41(16-17):1326-9. PubMed ID: 18801353
[TBL] [Abstract][Full Text] [Related]
9. Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.
Djurić T; Zivković M; Stanković A; Mecanin S; Alavantić D
J Clin Lab Anal; 2005; 19(6):241-6. PubMed ID: 16302209
[TBL] [Abstract][Full Text] [Related]
10. Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
Krishnaveni D; Bhayal AC; Shravan KP; Jyothy A; Pratibha N; Venkateshwari A
Indian J Cancer; 2015; 52(2):251-4. PubMed ID: 26853425
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
12. MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion.
Maqbool A; Keswani A; Galloway S; O'Regan DJ; Ball SG; Turner NA; Porter KE
J Surg Res; 2012 Jun; 175(2):343-9. PubMed ID: 21601886
[TBL] [Abstract][Full Text] [Related]
13. Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
Marasini B; Massarotti M; De Monti M; Erario M; Ghilardi G; Biondi ML
J Clin Immunol; 2008 Mar; 28(2):131-3. PubMed ID: 17975717
[TBL] [Abstract][Full Text] [Related]
14. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
Chiou KR; Chung SL; Charng MJ
J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression.
Medley TL; Kingwell BA; Gatzka CD; Pillay P; Cole TJ
Circ Res; 2003 Jun; 92(11):1254-61. PubMed ID: 12750310
[TBL] [Abstract][Full Text] [Related]
16. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Kim JS; Park HY; Kwon JH; Im EK; Choi DH; Jang YS; Cho SY
Yonsei Med J; 2002 Aug; 43(4):473-81. PubMed ID: 12205736
[TBL] [Abstract][Full Text] [Related]
17. Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
Huang XY; Han LY; Huang XD; Guan CH; Mao XL; Ye ZS
Int J Neurosci; 2016 Oct; 126(10):936-41. PubMed ID: 26314579
[TBL] [Abstract][Full Text] [Related]
18. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
19. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
Rauramaa R; Väisänen SB; Luong LA; Schmidt-Trücksäss A; Penttilä IM; Bouchard C; Töyry J; Humphries SE
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2657-62. PubMed ID: 11116068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
